Julia Schieber
Baker McKenzie Switzerland AGBaker McKenzie Switzerland AG leverages its international network to assist clients with a broad range of issues, including licence and employment agreements, and clinical trail strategy. The practice is jointly led by Olha Demianiuk and Julia Schieber. Demianiuk has a great deal of expertise in multi-jurisdictional M&A and health product portfolio acquisitions. Noted for her ‘profound’ industry knowledge, Schieber primarily focuses on IP and IT related issues, including the exploitation of IP rights, and collaboration and R&D agreements. Matthias Courvoisier leads the firm’s capital markets team, acting in a number of public takeovers and IPOs.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Good people with knowledge, quick answers, always available.’
‘Very experienced and well connected.’
‘Well-researched and pragmatic advice across multiple jurisdictions.’
‘It is an absolute pleasure to work with Julia Schieber, she is a very fast thinker, provides business oriented, thoughtful and pragmatic advice and is an excellent thought partner on tricky issues. She has profound industry knowledge.’
Key clients
- Abbott
- Abbvie
- Actelion Pharmaceuticals AG
- Adagene AG
- Alexion
- Allecra Therapeutics AG
- Argenx SE
- Aricium
- Baitella Holding AG
- Basilea Pharmaceutica AG
- Bausch Health Corporation
- Baxalta Inc
- Baxter
- Becton Dickinson
- Bruker BioSpin
- Cassiopea SpA
- Celgene
- Cell Medica Ltd
- Cosmo Pharmaceutical NV
- CSL Behring Beteiligungs- und Verwaltungs GmbH & Co KG
- Curasept A.D.S. S.r.l.
- CureTeq AG
- CureVac AG
- DocMorris
- Galapagos
- Galderma
- GSK
- Implantica AG
- Mapreg SAS
- Medmix
- Mérieux Equity Partners
- Moderna
- Novaliq
- Novartis
- Numab
- OnlineDoctor
- Sandoz
- Sanofi Aventis (Suisse) SA
- Similasan
- Sonova AG
- Takeda
- The International Federation of Pharmaceutical Manufacturers & Associations
- Zur Rose Group
Work highlights
- Advised GSK plc in a license agreement with WuXi Biologics under which GSK will have exclusive licenses for up to four bi- & multi-specific TCE antibodies developed using WuXi Biologics’ proprietary technology platforms.
- Advising BD Switzerland Sàrl on various employment matters , including review of employment agreements and assistance in relation to termination of employees.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Olha Demianiuk, Julia Schieber